Author

Matthias P. A. Ebert

Heidelberg University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Adelheid CerwenkaiD· 1 shared Bernhard Willibald RenziD· 1 shared Carsten StichtiD· 1 shared Chenjun HuangiD· 1 shared Chunfang GaoiD· 1 shared Dominik KatoiD· 1 shared Donato InversoiD· 1 shared Elisa Holstein· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adelheid CerwenkaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transient suppression of the ECM1 gatekeeper is essential for HGF/c-MET-driven liver regeneration

Ye Yao, Yujia Li, Chenjun Huang, Jiayi Ma, Liang Xu, Stephanie D. Wolf, Julian Gilljam, Haifeng Zeng, Stefan Munker, Xioachun Cao-Ehlker, Ruochan Li, Bernhard Willibald Renz, Hanno Nieß, Seddik Hammad, Elisa Holstein, , Sai Wang

This study identifies ECM1 as a gatekeeper that transiently suppresses HGF activity during liver regeneration, enabling tissue repair through c-MET-ERK-MYC signaling.

bioRxiv · Jun 10, 2026 · PreprintCell Biology

Macrophages target PVR/CD155 on colorectal cancer cells via REVERBalpha

Dominik Kato, Yu Han, Laura Helm, Frank Herweck, Natalia Schichta, Lennart Malz, Katharina Herrmann, Mohammad Saad Farooq, Veronika Hauber, Tobias Gutting, Johannes Betge, Carsten Sticht, Timo Gaiser, Adelheid Cerwenka, Matthias P. A. Ebert, Elke Burgermeister

This study shows that macrophages target PVR/CD155 on colorectal cancer cells via REVERBα, suggesting a new therapeutic strategy for MSS+ CRC.

bioRxiv · Jan 29, 2026 · PreprintCancer Biology